These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32728806)

  • 1. Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration : Status February 2020.
    ; ;
    Ophthalmologe; 2021 Jan; 118(Suppl 1):31-39. PubMed ID: 32728806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration : Status February 2020].
    ; ;
    Ophthalmologe; 2020 Aug; 117(8):746-754. PubMed ID: 32462232
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Asscociation of Ophthalmologists (BVA). Stand 15.10.2022].
    ; ;
    Klin Monbl Augenheilkd; 2023 Feb; 240(2):180-189. PubMed ID: 36812925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-VEGF therapy in neovascular age-related macular degeneration : Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Asscociation of Ophthalmologists (BVA). Stand 15.10.2022].
    ; ;
    Ophthalmologie; 2023 Feb; 120(2):169-177. PubMed ID: 36512119
    [No Abstract]   [Full Text] [Related]  

  • 5. [Supplementary statement of the German Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on laser treatment of drusen in age-related macular degeneration (AMD) : Status October 2018].
    ; ;
    Ophthalmologe; 2019 Feb; 116(2):138-143. PubMed ID: 30547187
    [No Abstract]   [Full Text] [Related]  

  • 6. [Supplementary Statement on IVOM Drugs for the Treatment of Diabetic Macular Edema with Foveal Involvement - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022].
    ; ;
    Klin Monbl Augenheilkd; 2023 Mar; 240(3):327-331. PubMed ID: 36977429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity : Released: 18 May 2020].
    ; ;
    Ophthalmologe; 2020 Sep; 117(9):873-885. PubMed ID: 32696195
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-VEGF therapy for neovascular age-related macular degeneration -therapeutic strategies: statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of Ophthalmologists in Germany - November 2014].
    Deutsche Ophthalmologische Gesellschaft
    Ophthalmologe; 2015 Mar; 112(3):237-45. PubMed ID: 25739373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].
    ; ;
    Ophthalmologe; 2018 May; 115(5):388-399. PubMed ID: 29572685
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].
    ; ;
    Ophthalmologe; 2021 Feb; 118(2):121-138. PubMed ID: 33346894
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statement of the Professional Association of German Ophthalmologists (BVA) and German Ophthalmological Society (DOG) on the revision of the advanced training regulations exemplified by emergency treatment: network sectors in order to ensure quality in advanced training : Intersectoral ophthalmology-joint committee of the DOG and BVA. Situation January 2020].
    ;
    Ophthalmologe; 2020 May; 117(5):437-438. PubMed ID: 32124001
    [No Abstract]   [Full Text] [Related]  

  • 12. [Supplementary statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of German Ophthalmologists (BVA) on treatment of proliferative diabetic retinopathy : Status November 2019].
    ; ;
    Ophthalmologe; 2020 Aug; 117(8):755-759. PubMed ID: 32430606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Supplementary statement on IVOM drugs for the treatment of diabetic macular edema with foveal involvement : Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022].
    ; ;
    Ophthalmologie; 2023 Mar; 120(3):273-275. PubMed ID: 36538082
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of German Ophthalmologists: The anti-VEGF therapy in neovascular age-related macular degeneration: Therapeutic Strategies (November 2014)].
    Gesellschaft DO
    Klin Monbl Augenheilkd; 2015 Feb; 232(2):202-10. PubMed ID: 25700258
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statement on ophthalmological examination for suspected shaken baby syndrome (SBS). : Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG), the German Professional Association of Ophthalmologists (BVA) in cooperation with German Society for Child Protection in Medicine (DGKiM). Status: June 2023].
    ; ; ;
    Ophthalmologie; 2023 Dec; 120(12):1233-1237. PubMed ID: 37773527
    [No Abstract]   [Full Text] [Related]  

  • 16. [Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the Professional Association of German Ophthalmologists (BVA) on the therapeutic use of voretigene neparvovec-rzyl (Luxturna™) in ophthalmology : Situation January 2019].
    ; ;
    Ophthalmologe; 2019 Jun; 116(6):524-533. PubMed ID: 31016385
    [No Abstract]   [Full Text] [Related]  

  • 17. [Integrated emergency centers for ophthalmology (INZ-A)-model of cross-sectoral cooperation : Statement of the joint committee "Cross-sectoral ophthalmology" of the German Ophthalmological Society (DOG) and the Professional Association of German Ophthalmologists (BVA)].
    ;
    Ophthalmologe; 2019 Oct; 116(10):940-941. PubMed ID: 31468125
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].
    ; ;
    Ophthalmologe; 2022 Feb; 119(2):148-162. PubMed ID: 34905071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
    Klin Monbl Augenheilkd; 2007 Jul; 224(7):559-66. PubMed ID: 17657689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statement of the German Society of Ophthalmology, the German Retina Society, and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity : Released: 18 May 2020.
    ; ;
    Ophthalmologe; 2021 Jan; 118(Suppl 1):68-77. PubMed ID: 33146773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.